Sentinel lymph nodes biopsy in the surgical treatment of endometrial cancer: history and present-Reference-Cited by-同舟云学术

Sentinel lymph nodes biopsy in the surgical treatment of endometrial cancer: history and present

Published:2019-02-21 Issue:4 Volume:14 Page:65-71
ISSN:1999-8627
Container-title:Tumors of female reproductive system
language:
Short-container-title:Opuholi ženskoj reproduktivnoj sistemy

Author:

Ochirov M. O.¹^ORCID,Kishkina A. Yu.¹^ORCID,Kolomiets L. A.²,Chernov V. I.³

Affiliation:

1. Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences

2. Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University

3. Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; National Research Tomsk Polytechnic University

Abstract

This article reviews the concept of sentinel lymph node biopsy in patients with endometrial cancer. This technique is becoming increasingly appreciated and was included into the latest standards of surgical treatment for gynecological cancers. Sentinel lymph node mapping is a reliable and highly specific (100 %) method, which can be used for determining the indications for adjuvant therapy in addition to a detailed pathomorphological examination that should include immunohistochemical testing and ultrastaging.

Publisher

Publishing House ABV Press

Subject

Pharmacology (medical),Obstetrics and Gynecology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference49 articles.

1. Creasman W.T., Odicino F., Maisonneuve P. et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95(Suppl 1): S105–43. PMID: 17161155. DOI: 10.1016/S0020-7292(06)60031-3.

2. Gehrig P.A., Clark L.H. The role of lymphadenectomy in endometrial cancer, Part 1. Ob Gyn News 2016. Available at: https://www.mdedge.com/obgyn/article/111789/gynecologic-cancer/rolelymphadenectomy-endometrial-cancerpart-1.

3. Ballester M., Dubernard G., Lécuru F. et al. Detection rate and diagnostic accuracyof sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 2011;12(5):469–76. DOI: 10.1016/S1470-2045(11)70070-5.

4. Havrilesky L.J., Cragun J.M., Calingaert B. et al. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol 2005;99(3):689–95. PMID: 16126261. DOI: 10.1016/j.ygyno.2005.07.014.

5. Bristow R.E., Zahurak M.L., Alexander C.J. et al. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer 2003;13(5):664–72. PMID: 14675352.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenetic characteristics of endometrioid adenocarcinoma of uterus at present stage;Medical alphabet;2024-01-17

2. Diagnostic value of ICG for sentinel lymph node mapping in patients with stage I endometrial cancer;Siberian journal of oncology;2024-01-01

3. Determination of sentinel lymph nodes in gynecological cancer using the radiopharmaceutical Sentiscan. A case series;Journal of Modern Oncology;2023-05-17